Nasdaq-listed Elicio Therapeutics has hired Megan Filoon as general counsel. In her new role, Filoon oversees corporate governance and compliance functions at the company.
She was most recently general counsel and corporate secretary at Molecular Templates, a publicly traded, oncology-focused biotech firm. In that position she advised the company’s board of directors and management team on corporate governance, securities, employment and real estate matters, among other areas, and was responsible for managing the legal, human resources and administrative departments.
Filoon joined Molecular Templates in 2018 as corporate counsel and was promoted to more senior roles before becoming general counsel in February 2022. Before her time at the company, she was a corporate associate at law firm Blank Rome, where she represented public and private companies in corporate governance, M&A, securities offerings and business formation matters.
Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of immunotherapies for the treatment of cancer. It has also hired Dr Thian Kheoh as senior vice president of biometrics.
Robert Connelly, CEO of Elicio Therapeutics, says in a statement: ‘Megan and Thian are joining us at an exciting time following our recent transition to a public company and as we continue to advance our lead clinical cancer vaccine candidate… Megan and Thian further strengthen an outstanding leadership team and their expertise will be invaluable in strengthening our legal and compliance functions and processing data from our Amplify trials, respectively.’
Â
Ben Maiden
Ben Maiden is the editor-at-large of Governance Intelligence, an IR Media publication, having joined the company in December 2016. He is based in New York. Ben was previously managing editor of Compliance Reporter, covering regulatory and compliance...
